Clinical trial
Role of Small Bioactive Molecules in the Progression of Early COPD Diseases
NCT04950023 is registered in ClinicalTrials.gov with Peking University Third Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Role of Small Bioactive Molecules in the Progression of Early COPD Diseases
- Lead sponsor
- Peking University Third Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- May 11, 2021
- Completion date
- May 11, 2024
- Enrollment
- 550 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic obstructive pulmonary disease